A new redness reliever like no other

LUMIFY (brimonidine tartrate ophthalmic solution 0.025%) is the first and only over-the-counter (OTC) eye drop developed with low-dose brimonidine tartrate for the treatment of ocular redness due to minor eye irritations. 


  • First and only OTC eye drop with low-dose Brimonidine Tartrate (0.025%)
  • Clinically proven safe and effective
  • Starts working in 1 minute - lasts for up to 8 hours

Use as directed.


LUMIFY is so effective at reducing redness, your patients will see the difference almost immediately.*




reported significant improvement
in just one minute



maintained significant redness reduction
at eight hours


Images representative of clinical trials results individual results may vary
* Based on patient reported findings from Phase 3.

LUMIFY is the only OTC redness reliever that primarily constricts the venule.

Other OTC redness relievers
(α1 or α1/α2-AR agonist)

  • Commonly associated with
    rebound redness and tachyphylaxis
  • Act on the arteriole, decreasing
    blood and oxygen flow to
    surrounding tissue.

LUMIFY with low dose Brimonidine
(Selective α2-AR agonist)

  • No tachyphylaxis and virtually
    no rebound redness in clinical trials
  • LUMIFY selectively constricts the
    venule, while maintaining availability
    of oxygen to surrounding tissue.

Phase III efficacy study2:

Overall, six clinical studies were conducted in over 600 patients to evaluate safety and efficacy, with low risk of allergic reactions among all patient groups.



Drug Facts


Active ingredient                          Purpose

Brimonidine tartrate (0.025%).........................Redness reliever

Use

  • relieves redness of the eye due to minor eye irritations

Warnings

For external use only

Do not use

  • if solution changes color or becomes cloudy

Stop use and ask a doctor if

  • you experience eye pain, changes in vision, continued redness or irritation of the eye
  • condition worsens or persists for more than 3 days

If pregnant or breast-feeding, ask a health professional before use. 
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • adults and children 5 years of age and over:
    • instill 1 drop in the affected eye(s) every 6-8 hours
    • do not use more than 4 times daily
    • remove contact lenses before use
    • wait at least 10 minutes before re-inserting contact lenses after use
    • if using other ophthalmic products while using this product, wait at least 5 minutes between each product
    • to avoid contamination, do not touch tip of container to any surface
    • replace cap after each use
  • children under 5 years of age: consult a doctor

Other information

  • store at 15°-25°C (59°-77°F)

Inactive ingredients

benzalkonium chloride, boric acid, calcium chloride dihydrate, glycerin, potassium chloride, sodium borate decahydrate, sodium chloride, water for injection. Hydrochloric acid and/or sodium hydroxide may be used to adjust pH.

 

* P<0.0001 between visit 1 and visit 2; P<0.0005 between visit 2 and visit 3
1 McLaurin E, Cavet ME, Gomes PJ, Ciolini JB. Brimonidine ophthalmic solution, 0.025% for reduction of ocular redness. Optom Vis Sci. 2018, in press. One reported case of rebound hyperemia in Phase III Safety Study.
2 Phase III was a double-blinded, randomized, placebo controlled study. n=60.

LUM.0067.USA.18

In the News